Mesoblast Limited Sponsored ADR MESO 深 滬
已收盤 02-06 16:00:00 美东时间
15.95
-0.130
-0.81%
華盛通- 最 高16.07
- 今 開15.74
- 成交量 28.40万股
- 最 低 15.55
- 昨 收 16.08
- 總市值 20.58亿
- 52周最高 21.50
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 9.61
- 委 比 -42.10%
- 總股本 1.29亿
- 歷史最高 58.4372
- 量 比 1.49
- 振 幅 3.23%
- 歷史最低 1.9406
- 每 手 1
- 風險率 2.85%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FDA Signals Support For Mesoblast's Cell Therapy For Chronic Back Pain
Mesoblast says FDA feedback supports filing plans for its cell therapy to treat chronic back pain, showing reduced pain and lower opioid use in a late-stage trial.
01-21 02:33
Mesoblast Stock Rises On Strong Year‑Over‑Year Growth In Ryoncil Sales
Mesoblast reported strong year‑over‑year growth in December quarter sales of its flagship therapy, Ryoncil.
01-10 01:34
Mesoblast shares are trading higher after the company reported a year-over-year increase in December Ryoncil sales results.
Mesoblast shares are trading higher after the company reported a year-over-year...
01-09 22:13
Mesoblast Lapses 3 Million Unquoted Warrants, Slightly Simplifying Capital Structure
The latest announcement is out from Mesoblast ( ($MESO) ). On January 6, 2026, ...
01-07 19:29
Mesoblast Director’s Warrant Lapse Trims Derivative Exposure Without Dilution
Mesoblast Limited ( ($AU:MSB) ) has issued an announcement. Mesoblast has discl...
01-06 15:47
Mesoblast Warrants Lapse as Conditions for Conversion Go Unsatisfied
An update from Mesoblast Limited ( ($AU:MSB) ) is now available. Mesoblast Limi...
01-06 15:37
Mesoblast Reshapes Board Leadership as It Deepens Commercial Focus
The latest update is out from Mesoblast Limited ( ($AU:MSB) ). Mesoblast Limite...
01-02 07:38
Mesoblast Announces Changes to Board of Directors' Leadership Roles
Mesoblast Limited announced leadership changes, with Jane Bell retiring as Chair and Philip Facchina appointed as non-executive Chair, and Lyn Cobley as Audit and Risk Committee Chair. The company is transitioning to a commercial entity, focusing on revenue generation and enhancing U.S. expertise to maximize shareholder value.
01-01 23:02
Mesoblast to Release 10.2 Million Shares From Voluntary Escrow
Mesoblast Limited ( ($AU:MSB) ) just unveiled an announcement. Mesoblast Limite...
2025-12-30 13:32
Mesoblast Cuts Cost of Capital With New US$125m Non‑Dilutive Credit Line
Mesoblast Limited ( ($AU:MSB) ) has shared an announcement. Mesoblast has refin...
2025-12-30 07:18
